Exicure Stock Year To Date Return
| XCUR Stock | USD 18.67 2.93 18.61% |
Exicure fundamentals help investors to digest information that contributes to Exicure's financial success or failures. It also enables traders to predict the movement of Exicure Stock. The fundamental analysis module provides a way to measure Exicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Exicure stock.
Exicure | Year To Date Return |
Exicure Company Year To Date Return Analysis
Exicure's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Exicure Year To Date Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Exicure is extremely important. It helps to project a fair market value of Exicure Stock properly, considering its historical fundamentals such as Year To Date Return. Since Exicure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Exicure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Exicure's interrelated accounts and indicators.
Click cells to compare fundamentals
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
| Competition |
Exicure Return On Tangible Assets
Return On Tangible Assets |
|
As per the company's disclosures, Exicure has a Year To Date Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Exicure Year To Date Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exicure's direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exicure could also be used in its relative valuation, which is a method of valuing Exicure by comparing valuation metrics of similar companies.Exicure is currently under evaluation in year to date return category among its peers.
Exicure ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Exicure's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Exicure's managers, analysts, and investors.Environmental | Governance | Social |
Exicure Fundamentals
| Return On Equity | -1.44 | ||||
| Return On Asset | -0.26 | ||||
| Operating Margin | (11.93) % | ||||
| Current Valuation | 60.88 M | ||||
| Shares Outstanding | 3.04 M | ||||
| Shares Owned By Insiders | 46.70 % | ||||
| Shares Owned By Institutions | 4.28 % | ||||
| Number Of Shares Shorted | 93.87 K | ||||
| Price To Book | 35.66 X | ||||
| Price To Sales | 113.48 X | ||||
| Gross Profit | 9.06 M | ||||
| EBITDA | (15.54 M) | ||||
| Net Income | (16.91 M) | ||||
| Cash And Equivalents | 22.2 M | ||||
| Cash Per Share | 4.47 X | ||||
| Total Debt | 6.67 M | ||||
| Debt To Equity | 6.53 % | ||||
| Current Ratio | 1.26 X | ||||
| Book Value Per Share | 1.75 X | ||||
| Cash Flow From Operations | (10.36 M) | ||||
| Short Ratio | 0.19 X | ||||
| Earnings Per Share | (2.02) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 56.74 M | ||||
| Total Asset | 11.58 M | ||||
| Retained Earnings | (189.56 M) | ||||
| Working Capital | (486 K) | ||||
| Net Asset | 11.58 M |
About Exicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Exicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Exicure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exicure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will appreciate offsetting losses from the drop in the long position's value.Moving together with Exicure Stock
| 0.81 | DMAC | DiaMedica Therapeutics Upward Rally | PairCorr |
Moving against Exicure Stock
| 0.85 | VALN | Valneva SE ADR | PairCorr |
| 0.84 | DRRX | Durect | PairCorr |
| 0.82 | VIGL | Vigil Neuroscience | PairCorr |
| 0.76 | DTIL | Precision BioSciences | PairCorr |
| 0.69 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Exicure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exicure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exicure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exicure to buy it.
The correlation of Exicure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exicure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exicure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exicure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Exicure Stock Analysis
When running Exicure's price analysis, check to measure Exicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exicure is operating at the current time. Most of Exicure's value examination focuses on studying past and present price action to predict the probability of Exicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exicure's price. Additionally, you may evaluate how the addition of Exicure to your portfolios can decrease your overall portfolio volatility.